1. HOXA5 Is Recognized as a Prognostic-Related Biomarker and Promotes Glioma Progression Through Affecting Cell Cycle;Ding;Front. Oncol.,2021
2. Identification of a novel cell-penetrating peptide targeting human glioblastoma cell lines as a cancer-homing transporter;Higa;Biochem. Biophys. Res. Commun.,2015
3. Local Delivery and Glioblastoma: Why Not Combining Sustained Release and Targeting?;Gazaille;Front. Med. Technol.,2021
4. Efficacy and Safety of Temozolomide Combined with Radiotherapy in the Treatment of Malignant Glioma;Wei;J. Healthc. Eng.,2022
5. Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide;Messaoudi;Int. J. Nanomed.,2014